Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 1/2017

01-07-2017 | Correspondence

Factors affecting serum sclerostin in postmenopausal women

Author: Tomoyuki Kawada

Published in: Archives of Gynecology and Obstetrics | Issue 1/2017

Login to get access

Excerpt

I read with interest the article titled “The relationship between postmenopausal women’s sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products” by Kalem et al. [1]. The authors investigated the relationship between serum sclerostin levels, bone mineral density, and other related factors in 135 postmenopausal women. There was a positive relationship between serum sclerostin levels and body mass index in all subjects and also in sub-population, stratified by the existence of osteoporosis. In addition, negative relationships between serum sclerostin levels and bone mineral density scores in several parts of the body were observed, which were independent from age. Furthermore, there was no significant difference in the mean value of serum sclerostin levels in relation to smoking, coffee consumption, milk and dairy products, bisphosphonate use, histories of hypertension, and diabetes. I have a query about their study with special reference to statistical method. …
Literature
1.
go back to reference Kalem MN, Kalem Z, Akgun N, Bakırarar B (2017) The relationship between postmenopausal women’s sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products. Arch Gynecol Obstet 295:785–793CrossRefPubMed Kalem MN, Kalem Z, Akgun N, Bakırarar B (2017) The relationship between postmenopausal women’s sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products. Arch Gynecol Obstet 295:785–793CrossRefPubMed
2.
go back to reference Marill KA (2004) Advanced statistics: linear regression, part II: multiple linear regression. Acad Emerg Med 11:94–102CrossRefPubMed Marill KA (2004) Advanced statistics: linear regression, part II: multiple linear regression. Acad Emerg Med 11:94–102CrossRefPubMed
3.
go back to reference Honasoge M, Rao AD, Rao SD (2014) Sclerostin: recent advances and clinical implications. Curr Opin Endocrinol Diabetes Obes 21:437–446CrossRefPubMed Honasoge M, Rao AD, Rao SD (2014) Sclerostin: recent advances and clinical implications. Curr Opin Endocrinol Diabetes Obes 21:437–446CrossRefPubMed
4.
go back to reference Appelman-Dijkstra NM, Papapoulos SE (2016) From disease to treatment: from rare skeletal disorders to treatments for osteoporosis. Endocrine 52:414–426CrossRefPubMedPubMedCentral Appelman-Dijkstra NM, Papapoulos SE (2016) From disease to treatment: from rare skeletal disorders to treatments for osteoporosis. Endocrine 52:414–426CrossRefPubMedPubMedCentral
Metadata
Title
Factors affecting serum sclerostin in postmenopausal women
Author
Tomoyuki Kawada
Publication date
01-07-2017
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 1/2017
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4394-9

Other articles of this Issue 1/2017

Archives of Gynecology and Obstetrics 1/2017 Go to the issue